Experts propose 'cyber war' on cancer
In the face of mounting evidence that cancer cells communicate, cooperate and even engage in collective decision-making, biophysicists and cancer researchers at Rice University, Tel Aviv University and Johns ...
Cancer
Sep 04, 2012 |
4.7 / 5 (3) |
0
|
Study targets non-small cell lung cancer
A Phase I/II, multi-center trial designed to test the safety and preliminary efficacy of a first in class cancer treatment opened worldwide today at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, ...
Cancer
Aug 29, 2012 |
5 / 5 (1) |
0
Study helps pancreatic cancer patients make hard choices
Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter ...
Cancer
Aug 23, 2012 |
2 / 5 (1) |
0
Prolonged dexamethasone cuts delayed nausea after chemo
(HealthDay) -- Adding dexamethasone to prochlorperazine on days two and three, following palonosetron and dexamethasone on day one, reduces delayed nausea (DN) in patients receiving chemotherapy containing ...
Cancer
Aug 22, 2012 |
not rated yet |
0
Researchers investigate drug resistant ovarian cancer to improve clinical treatment
(Medical Xpress) -- A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase ...
Cancer
Aug 09, 2012 |
not rated yet |
0
New biomarker for common lung cancer predicts responses to chemotherapy
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published ...
Cancer
Jul 26, 2012 |
not rated yet |
0
Metastatic breast cancer: Bevacizumab slows progression, but has no impact on survival
The cancer drug bevacizumab (Avastin) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed ...
Cancer
Jul 10, 2012 |
not rated yet |
0
Biomarker predicts chemo response for osteosarcoma
(Medical Xpress) -- Scientists have found that a protein expressed by some cancers is a good predictor of how the cancer will respond to standard chemotherapy for osteosarcoma, the most common bone cancer in children. Knowing ...
Cancer
Jul 03, 2012 |
not rated yet |
0
|
Researchers block pathway to cancer cell replication
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer stem cells. In such cancers, the cells lie ...
Cancer
Jul 02, 2012 |
not rated yet |
0
|
Progress in quest to reduce use of radiation in treatment of pediatric Hodgkin lymphoma
A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at risk for second cancers, ...
Cancer
Jun 26, 2012 |
not rated yet |
0
|
Metformin treatment caused cancer stem cell death in pancreatic cancer cell lines
Results of some preclinical trials have shown that low doses of the antidiabetic drug metformin may effectively destroy cancer stem cells, a group of cells that are considered to be responsible for tumor initiation and, because ...
Cancer
Jun 19, 2012 |
not rated yet |
0
Gene clue to drug resistance in African sleeping sickness
(Medical Xpress) -- Researchers have identified a gene that controls susceptibility to drug treatment in Trypanosoma brucei, the parasite responsible for African sleeping sickness.
Diseases, Conditions, Syndromes
Jun 19, 2012 |
3 / 5 (2) |
0
|
Multi-center clinical study intensifies first strike at high-risk cancer in kids
An experimental treatment that combines intense chemotherapy with a radioactive isotope linked to synthesized neurotransmitter is being tested in newly diagnosed cases of high-risk neuroblastoma – a deadly, hard-to-cure ...
Cancer
Jun 12, 2012 |
not rated yet |
0
Study: Heart damage after chemo linked to stress in cardiac cells
Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests.
Cardiology
May 21, 2012 |
not rated yet |
1
|
ASCO: For chemo's nausea, olanzapine beats metoclopramide
(HealthDay) -- For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine (Zyprexa) is significantly better than treatment ...
Cancer
May 17, 2012 |
not rated yet |
0
